NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

AVECHO BIOTECHNOLOGY LIMITED (AVE)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of AVE: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000047441
Address: Unit A8, 2A Westall Road Clayton Victoria 3168
Tel:  +61 3 9002 5000Fax: +61 3 9565 1151

Date first listed: 09/08/1993
Company Secretary: Melanie Leydin
Sector: Pharmaceuticals Biotechnology & Life Sciences Industry Group: XHJ
Activities: Avecho is focused on developing and commercialising innovative Human Health, Animal Health and Personal Care products using its proprietary drug delivery system, TPM

News & Events

Expand this box to read and print

The suspension of trading in the securities of Avecho Biotechnology Limited will be lifted immediately following the release by AVE of an announcement regarding a capital raising.

28/08/2023

The company releases a notification of proposed issue of securities.

28/08/2023

Avecho has received firm commitments to raise $6m via a placement. Placement supported by existing shareholders, together with new sophisticated and institutional investors. The placement will be used to advance Avecho's pivotal phase III clinical trial.

28/08/2023

The securities of Avecho Biotechnology Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of AVE, pending the release of an announcement regarding a capital raising.

25/08/2023

The suspension of trading in options will be lifted immediately, following the release of an announcement regarding the outcome of the application to the Federal Court of Australia seeking orders in respect of the options being issued without disclosure.

14/07/2022

The quoted options (ASX Code: AVEO) of Avecho Biotechnology Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of AVE, pending the release of a cleansing prospectus and court orders being obtained in relation to the options. Please note that the suspension only applies to the quoted options (ASX Code: AVEO), and does not apply to any other quoted securities of AVE.

08/06/2022

name changed from Phosphagenics Limited

27/05/2019

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    02/03/2017David Segal500,000$0.020$10,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Greg CollierNon Exec Chairman13/04/2015
    Paul GavinCEO01/05/2020
    Roksan LibinakiCOO01/05/2020
    Melanie LeydinCFO28/12/2018
    Ross MurdochNon Exec Director14/01/2015
    Matthew McNamaraNon Exec Director13/01/2020

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    David SegalNon Exec Director19/05/201631/05/2021
    Anna LeggCFO22/01/201324/12/2018
    Peter LankauIndependent Director13/04/201525/05/2018
    Geert CauwenberghIndependent Director03/03/201430/05/2017
    Nathan DronaIndependent Director03/03/201418/05/2016
    Harry RosenDirector07/06/199910/07/2015
    Lawrence GozlanNon Exec Chairman, Independent Director03/03/201412/05/2015
    Jonathan AddisonChairman, Non Exec Director19/11/200203/03/2014
    Stuart JamesNon Exec Director24/08/201003/03/2014
    Don ClarkeNon Exec Director24/08/201003/03/2014
    Sandra WebbNon Exec Director24/08/201003/03/2014
    Esra OgruCEO, Executive Director11/10/200518/07/2013
    Michael R. AshtonNon Exec Director08/07/200826/08/2010
    Andrew VizardChairman26/07/199902/06/2010
    Michael PrestonNon Exec Director08/11/200425/05/2008
    Ian PattisonCOO04/03/200402/07/2006
    Simon M. WestNon Exec Director07/06/199920/03/2004
    Peter LewinskyNon Exec Director07/06/199920/03/2004
    Alan D. FisherNon Exec Director23/10/200018/03/2004
    Steve KormanNon Exec Director23/10/200013/02/2004

    Date of first appointment, title may have changed.